← Back to Search

Procedure

Dry Needling for Stroke (CDN Trial)

N/A
Waitlist Available
Led By Gretchen Seif, DPT
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after ddn, 90 minutes after ddn, 24 hours after, and 72 hours after ddn
Awards & highlights

CDN Trial Summary

This trial is examining the effects of dry needling on spasticity in people with chronic stroke.

Eligible Conditions
  • Stroke
  • Spasticity

CDN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after ddn, 90 minutes after ddn, 24 hours after ddn, and 72 hours after ddn
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after ddn, 90 minutes after ddn, 24 hours after ddn, and 72 hours after ddn for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in cutaneous reflexes elicited by non-noxious stimulation of cutaneous or mix nerves
Changes in perception of cutaneous stimuli as measured by perception and radiating threshold of cutaneous nerve stimulation
H-Reflex
Secondary outcome measures
Change in ability to move the leg as measured by the Fugl-Meyer Assessment (FMA)
Pain
Change in spasticity as measured by the Modified Ashworth Scale (mAS)
+2 more

CDN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dry Needling Reflex MeasurementsExperimental Treatment1 Intervention
All participants who participated in baseline reflex measurements during week 1 will continue to the second week of the study (Visits 5-7). Participants will receive dry needling to relieve spasticity in the target calf muscle (middle gastrocnemius) during Visit 5. The study team will examine the effects of this treatment on the nervous system by performing assessments just prior to DDN, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN. These assessments will examine how you move your leg and how your nervous system responds to non-invasive nerve stimulation.
Group II: Non-Intervention Week Reflex MeasurementsActive Control1 Intervention
Baseline reflex measurements will be collected during the first week of the study (Visits 1-4). No dry needling will occur during this week. The aim of this arm is to track any natural variability in nervous system excitability at the same time points as reflex measurements during the intervention week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dry Needling
2020
Completed Phase 2
~1090

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,248 Total Patients Enrolled
67 Trials studying Stroke
60,039 Patients Enrolled for Stroke
National Institute of General Medical Sciences (NIGMS)NIH
268 Previous Clinical Trials
248,748 Total Patients Enrolled
9 Trials studying Stroke
242 Patients Enrolled for Stroke
Gretchen Seif, DPTPrincipal InvestigatorMedical University of South Carolina

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have signed up to partake in this experiment?

"Indeed, the details on clinicaltrials.gov confirm that this trial is actively seeking participants. It was initially posted on March 7th 2022 and has most recently been updated November 28th of 2022. The study requires 20 volunteers across a single medical centre."

Answered by AI

Are participants currently being sought for this trial?

"According to the information present on clinicaltrials.gov, this research endeavour is still open for recruitment of participants. It was initially advertised in March 2022 and has recently been updated at the end of November."

Answered by AI

What is the aim of this medical experiment?

"This medical trial measures cutaneous reflexes elicited by non-noxious stimulation of nerves, pain levels as measured on a 0 to 10 Visual Analogue Scale (VAS), walking time for the Ten Meter Walk Test, and spasticity using Modified Ashworth Scale (mAS) over 7 days prior. Secondary goals include decreasing VAS scores in order to reduce pain, mitigating issues with locomotion via reduced walk times and abating spasticity through decreased mAs ratings."

Answered by AI
~4 spots leftby Apr 2025